The CYP3A4∗1B polymorphism and prostate cancer susceptibility in a Portuguese population

Testosterone exposure has been implicated in prostate carcinogenesis, and genes that alter its metabolism, such as CYP3A4, have been associated with prostate cancer susceptibility. The aim of our study was to assess the relationship between the CYP3A4∗1B polymorphism and its possible role in the development of prostate cancer. DNA samples obtained from the peripheral blood cells of 414 individuals diagnosed with prostate cancer and 337 healthy male donors were used in this case–control study. The CYP3A4∗1B polymorphism was analyzed by polymerase chain reaction–restriction fragment length polymorphism methodology. We found no statistically significant differences in the distribution of the CYP3A4∗1B genotypes between cases and controls (P = 0.470; odds ratio = 1.191; 95% confidence interval=0.740–1.918), as well as after the stratification of our analysis, according to important clinicopathologic parameters of prostate cancer. Our results suggest that the CYP3A4∗1B polymorphism is not associated with prostate cancer risk within the Portuguese population.